Analysis of Endovascular Stent market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
An endovascular stent is a fabric tube grafted during the endovascular surgery to treat aneurysm by various surgical invasive procedures. The technological advancement in the field of surgical areas from open surgeries to the endovascular surgeries upsurge the demand for the endovascular stents.
According to American Heart Association, U.S. sets out to have more than 48% of the cardiovascular patients in 2019. Additionally, in 2015 according to CDC data estimation, more than 6,00, 000 patients fatal each year in U.S. owing to increased prevalence of abdominal aortic aneurysm (AAA) and was considered as the top cause for the mortality.
The COVID-19 outbreak has affected the global economy in several ways such as limited care units and ventilation sites, labor shortage, lack of raw materials and halt on transportation. The business complexities with respect to disruption of the production of medical devices has projected to show short-term negative impact on the global market. In addition, reduced hospital visits and reschedule of the surgeries due to COVID-19 outbreak is expected to decline short-term growth of the endovascular stent market during the forecast period.
Rising prevalence of aneurysm disease, and the cardiac complications within the growing geriatric population are the major factors that expected to drive the endovascular stent market growth during the forecast period. The frequent occurrence of the ailments such cardiovascular disorders, aortic aneurysm, or artery disease and inclination to minimally invasive surgical procedures has led to propel the endovascular stent market growth.
Furthermore, attribution to superior lifestyle choices such as alcohol consumption, smoking and unhealthy diet habits of an individual has been led to rise in the incidence of cardiovascular diseases that projected to drive the endovascular stent market during the forecast period. The high cost of the treatment and the associated complications expected to restrain the endovascular stent market growth during the forecast period.
The global endovascular stent market manifests a considerable growth during the forecast period owing to rise in prevalence of cardiovascular complications. Based on the product, the endovascular aneurysm repair (EVAR) stent segment hold the largest share owing to the technological advancement in the surgical devices anticipated the rising demand for the EVAR stents in the global endovascular stent market.
Based on the application, abdominal aortic aneurysm (AAA) segment dominated the endovascular stent market due to increased prevalence abdominal aortic aneurysm incidence in the region. Hospitals and the cardiovascular centers dominate end user segment owing to the availability of advanced medical devices, ease of treatment, with health policies assurance facilities.
North America expects to dominate the endovascular stent market during the forecast period owing to increasing prevalence of cardiovascular disease, acquired advanced treatment, and availability of reimbursement. Europe is the second leading region due to rise in geriatric population and rising adoption of medical devices in the region. South Asia and East Asia regions witnessed significant growth during the forecast period due to initiation of the regional government, and increasing healthcare expenditure that expects to drive the endovascular stent market
Other regions like Latin America and Middle East and Africa are emerging regions in the endovascular stent market.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The major players contributing in endovascular stent market are Abbott Laboratories, Boston Scientific Co., Medtronic plc, Cardinal Health, Inc., B. Braun Melsungen AG, Biotronik Se & Co., Cook Medical, Inc., Terumo Co., Microport Scientific Co., Meril Life Sciences Pvt Ltd., C.R. Bard, Vascular Concepts Ltd., VentureMed, Inc., W.L. Gore and Associates, Inc., Endologix, Inc., Translumina GmbH, Lombard Medical Technologies, and others.
The research report on endovascular stent market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on market provides analysis and information according to market segments such as products, applications, and end users.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Based on the product, the endovascular stent market is segmented as:
Based on the application, the endovascular stent market is segmented as:
Based on the end user, the endovascular stent market is segmented as:
Based on region, the endovascular stent market is segmented as:
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Research Methodology -
An Adaptive Approach to Modern-day Research NeedsGet Methodology
- Related Reports -
The technological advancement in the field of surgical areas from open surgeries to the endovascular surgeries upsurge the demand for the endovascular stents.
North America is expected to witness the highest growth over the forecast period.
The major key players are Abbott Laboratories, Boston Scientific Co., Medtronic plc, Cardinal Health, Inc., B. Braun Melsungen AG, and others.
Need An Exclusive Report For Your Unique Requirement?